These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21983597)

  • 41. Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages.
    Grechi J; Marinho-Carvalho M; Zancan P; Cinelli LP; Gomes AM; Rodrigues ML; Nimrichter L; Sola-Penna M
    J Biol Chem; 2011 Apr; 286(17):14820-9. PubMed ID: 21388964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans.
    Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S
    J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
    McFadden DC; De Jesus M; Casadevall A
    J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.
    Albuquerque PC; Fonseca FL; Dutra FF; Bozza MT; Frases S; Casadevall A; Rodrigues ML
    Future Microbiol; 2014; 9(2):147-61. PubMed ID: 24571070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
    Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML
    Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.
    Yauch LE; Mansour MK; Levitz SM
    Infect Immun; 2005 Dec; 73(12):8429-32. PubMed ID: 16299344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of Biologically Active Fractions Enriched with Glucuronoxylomannan, the Main Antigen of the Cryptococcal Capsule.
    Jozefowicz LJ; Rodrigues ML
    Methods Mol Biol; 2024; 2775():367-373. PubMed ID: 38758330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides.
    Klutts JS; Doering TL
    J Biol Chem; 2008 May; 283(21):14327-34. PubMed ID: 18347023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulatory Role of Capsular Polysaccharides Constituents of
    Decote-Ricardo D; LaRocque-de-Freitas IF; Rocha JDB; Nascimento DO; Nunes MP; Morrot A; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
    Front Med (Lausanne); 2019; 6():129. PubMed ID: 31275938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan.
    Oliveira DL; Nimrichter L; Miranda K; Frases S; Faull KF; Casadevall A; Rodrigues ML
    Fungal Genet Biol; 2009 Dec; 46(12):956-63. PubMed ID: 19747978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model.
    Devi SJ
    Vaccine; 1996 Jun; 14(9):841-4. PubMed ID: 8843625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Turner SH; Cherniak R
    Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration.
    Ellerbroek PM; Lefeber DJ; van Veghel R; Scharringa J; Brouwer E; Gerwig GJ; Janbon G; Hoepelman AI; Coenjaerts FE
    J Immunol; 2004 Dec; 173(12):7513-20. PubMed ID: 15585878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans.
    Pettoello-Mantovani M; Casadevall A; Kollmann TR; Rubinstein A; Goldstein H
    Lancet; 1992 Jan; 339(8784):21-3. PubMed ID: 1370335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.
    Rodrigues ML; Alvarez M; Fonseca FL; Casadevall A
    Eukaryot Cell; 2008 Apr; 7(4):602-9. PubMed ID: 18039942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of Secreted Carbohydrates that Present Immunologic Similarities with the Cryptococcus Glucuronoxylomannan by Members of the Trichosporonaceae Family: A Comparative Study Among Species of Clinical Interest.
    de Andrade IB; Almeida MA; Figueiredo-Carvalho MHG; Coelho RA; Chaves ALDS; Frases S; Zancopé-Oliveira RM; Brito-Santos F; Almeida-Paes R
    Mycopathologia; 2021 Jun; 186(3):377-385. PubMed ID: 33956292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.
    García-Rivera J; Chang YC; Kwon-Chung KJ; Casadevall A
    Eukaryot Cell; 2004 Apr; 3(2):385-92. PubMed ID: 15075268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.
    Fonseca FL; Frases S; Casadevall A; Fischman-Gompertz O; Nimrichter L; Rodrigues ML
    Fungal Genet Biol; 2009; 46(6-7):496-505. PubMed ID: 19285564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.
    Yoneda A; Doering TL
    Eukaryot Cell; 2008 Mar; 7(3):546-9. PubMed ID: 18156288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.